Kane Biotech Sues Nestlé

Posted in: Press Releases

Kane Biotech Sues Nestlé

WINNIPEG, Manitoba – (GlobeNewswire – February 26, 2018) – Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced that it has filed a lawsuit against Nestec, Ltd., a/k/a Nestec, S.A. (“Nestec”), and Nestlé Purina Petcare Global Resources, Inc.  (“Nestlé Purina”), (collectively “Nestlé”) for breach of agreements between the parties, and misappropriation of Kane Biotech’s trade secrets and intellectual property.   In the six-count complaint filed under seal in U.S. federal court in Missouri, Kane Biotech alleges, amongst other improper activities, that a Nestlé patent application makes improper use of Kane Biotech’s patent rights for oral care, personal care and wound care antimicrobial and anti-biofilm technologies that the Corporation developed.

Mark Ahrens-Townsend, President & CEO of Kane Biotech, said, “Kane Biotech has invested significantly in its intellectual property and it will vigorously protect and defend its interests and the interests of its shareholders against anyone who seeks to profit from it without proper compensation to our Corporation.”